Document Detail


Bcl-2 overexpression disrupts the morphology of PC12 cells through reduced ERK activation.
MedLine Citation:
PMID:  16914120     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Bcl-2 has been hypothesized to regulate many cellular functions in addition to its well-characterized role in the prevention of programmed cell death. To understand the role of Bcl-2 in regulating cell morphology and to explore the mechanism of this effect, we examined the effects of Bcl-2 overexpression on the morphology of PC12 cells in culture. We demonstrate that the overexpression of Bcl-2 in PC12 cells results in altered cell morphology and reduced actin expression. Analysis of extracellular signal-regulated kinase (ERK) 1/2 phosphorylation reveals that the morphological changes seen after bcl-2 transfection are associated with reduced ERK activation. Treatment of control (mock-transfected) PC12 cells with the mitogen-activated ERK-activating kinase (MEK) inhibitor PD98059 converts their flat, process-bearing morphology into the rounded, process-free morphology of bcl-2-transfected cells, further confirming the association of ERK activation with altered cell shape. In conclusion, the present study describes a novel function of Bcl-2 in regulating cell shape through reduced ERK activation.
Authors:
Zhiping Mi; Zeljka Korade Mirnics; Nina Felice Schor
Publication Detail:
Type:  Comparative Study; Journal Article; Research Support, N.I.H., Extramural     Date:  2006-08-17
Journal Detail:
Title:  Brain research     Volume:  1112     ISSN:  0006-8993     ISO Abbreviation:  Brain Res.     Publication Date:  2006 Sep 
Date Detail:
Created Date:  2006-09-18     Completed Date:  2006-11-28     Revised Date:  2013-06-03    
Medline Journal Info:
Nlm Unique ID:  0045503     Medline TA:  Brain Res     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  46-55     Citation Subset:  IM    
Affiliation:
Pediatric Center for Neuroscience, Children's Hospital of Pittsburgh of UPMC, Pittsburgh, PA 15213, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Actins / metabolism
Animals
Blotting, Western / methods
Enzyme Activation / physiology
Enzyme Inhibitors / pharmacology
Extracellular Signal-Regulated MAP Kinases / metabolism*
Flavonoids / pharmacology
Gene Expression / physiology*
PC12 Cells / cytology*,  metabolism*
Phalloidine / diagnostic use
Phosphorylation
Proto-Oncogene Proteins c-bcl-2 / physiology*
Rats
Time Factors
Grant Support
ID/Acronym/Agency:
R01-CA74289/CA/NCI NIH HHS; R01-NS38569/NS/NINDS NIH HHS; T32-NS07495/NS/NINDS NIH HHS
Chemical
Reg. No./Substance:
0/2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one; 0/Actins; 0/Enzyme Inhibitors; 0/Flavonoids; 0/Proto-Oncogene Proteins c-bcl-2; 17466-45-4/Phalloidine; EC 2.7.11.24/Extracellular Signal-Regulated MAP Kinases

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The synthetic cannabinoid WIN 55,212-2 increases COX-2 expression and PGE2 release in murine brain-d...
Next Document:  Role of the 5-HT2C receptor in improving weight-supported stepping in adult rats spinalized as neona...